Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma.
about
Diosmetin triggers cell apoptosis by activation of the p53/Bcl-2 pathway and inactivation of the Notch3/NF-κB pathway in HepG2 cellsSerum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinomaZinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer.MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2.Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated NeutrophilsSilencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cellsCurcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.Increased Expression of FGF19 Contributes to Tumor Progression and Cell Motility of Human Thyroid Cancer.Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype.Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A.Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
P2860
Q28468617-259A92F6-6593-4FFD-9AE7-397E8FFC54E6Q35744895-EBB5404E-463D-40AF-9871-CECA584FCF58Q36763534-9BF16A05-25DB-40B5-B48D-0D4D4BCBCB78Q37062650-8047C7DB-9036-42DB-A3D8-9D9469F31954Q37089248-D8C7103B-A655-487F-B78A-63E23A5B2E5BQ37096099-109F2224-1797-4AA0-A535-825273CA554BQ38777239-486BE69C-2AB0-4731-A20E-E65E3B4B3CDFQ38979450-E90DFCFB-E71A-4D51-8A5D-0EDE76CD7F5BQ40450069-0247A36E-8074-4878-951A-F684DE93B1AEQ42086850-030DAE45-B865-4CB3-B8D5-6F1237FD7DB9Q43526905-32451F7F-A8A3-4207-BA07-C717877FABD8Q49236880-94214ADC-D87B-4C20-84B0-2DF7F73D8B7CQ53551635-06932311-0648-41BF-8853-0E9ABF224F44
P2860
Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Overexpression of Chemokine (C ...... s in hepatocellular carcinoma.
@ast
Overexpression of Chemokine (C ...... s in hepatocellular carcinoma.
@en
Overexpression of Chemokine
@nl
type
label
Overexpression of Chemokine (C ...... s in hepatocellular carcinoma.
@ast
Overexpression of Chemokine (C ...... s in hepatocellular carcinoma.
@en
Overexpression of Chemokine
@nl
prefLabel
Overexpression of Chemokine (C ...... s in hepatocellular carcinoma.
@ast
Overexpression of Chemokine (C ...... s in hepatocellular carcinoma.
@en
Overexpression of Chemokine
@nl
P2093
P2860
P1476
Overexpression of Chemokine (C ...... s in hepatocellular carcinoma.
@en
P2093
P2860
P2888
P356
10.1186/S12935-014-0086-8
P577
2014-09-24T00:00:00Z
P5875
P6179
1051756015